Related Experiment Video
Updated: Jan 18, 2026

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
Current RNA-based Therapeutics in Clinical Trials.
Ling-Yan Zhou1, Zhou Qin1, Yang-Hui Zhu1,2
1Department of Pharmacy and Cancer Center, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan 610041, China.
RNA therapeutics, including antisense oligonucleotides and CRISPR-Cas, show great clinical potential for treating diseases by modulating gene expression. Further research into delivery and modifications is crucial for widespread clinical application.
Area of Science:
- Molecular Biology
- Genetics
- Biotechnology
Background:
- Long-term RNA research has unveiled diverse mechanisms.
- This has driven the rapid development of RNA-based therapeutics for clinical applications.
Purpose of the Study:
- To review advances and clinical studies of current RNA-based therapeutics.
- To analyze the challenges and prospects of RNA-based drug development.
Main Methods:
- Review of current literature on RNA-based therapeutics.
- Analysis of clinical trial outcomes and mechanisms of action.
- Discussion of delivery systems and RNA modification strategies.
Main Results:
- Various RNA therapeutics (antisense oligonucleotides, siRNAs, miRNAs, mRNA, aptamers, CRISPR-Cas) demonstrate potential.
- Clinical trials show promising results for treating diverse diseases.
- Delivery materials and RNA modifications require further optimization.
Conclusions:
- RNA-based drugs offer powerful therapeutic tools with significant clinical potential.
- Continued research is essential to overcome challenges and facilitate clinical translation.
- Optimizing delivery and modifications will enhance the efficacy and safety of RNA therapeutics.
More Related Videos
07:40Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Preclinical Development: Overview
Gene Therapy
Microorganisms in Medicine and Therapeutics